David M. Knott Jr’s Syndax Pharmaceuticals SNDX Stock Holding History

David M. Knott Jr’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.56M	Buy	437,245 +15,245	+4%	+$317K	5.05%	3
2026 Q1	$9.86M	Buy	422,000 +7,000	+2%	+$152K	5.87%	3
2025 Q4	$8.72M	Sell	415,000 -13,000	-3%	-$227K	4.04%	4
2025 Q3	$6.58M	Buy	428,000 +75,222	+21%	+$985K	2.66%	7
2025 Q2	$3.3M	Buy	352,778 +224,778	+176%	+$2.47M	1.5%	14
2025 Q1	$1.57M	Hold	128,000	–	–	0.74%	22
2024 Q4	$1.69M	Buy	128,000 +5,856	+5%	+$100K	0.61%	24
2024 Q3	$2.35M	Buy	122,144 +18,318	+18%	+$378K	0.83%	30
2024 Q2	$2.13M	Buy	103,826 +38,351	+59%	+$803K	0.85%	26
2024 Q1	$1.56M	Buy	+65,475	New	+$1.46M	0.55%	33

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

David M. Knott Jr's SNDX Position: Q2 2026 in Review

David M. Knott Jr increased its Syndax Pharmaceuticals (SNDX) stake by 3.6% in Q2 2026, buying an estimated $317K and bringing the position to 437,245 shares worth $9.56M. The position accounts for 5.05% of the portfolio, ranked #3.

David M. Knott Jr first reported a position in SNDX in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.86M in Q1 2026. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

David M. Knott Jr held 437,245 shares of Syndax Pharmaceuticals worth $9.56M as of Q2 2026.
David M. Knott Jr bought 15,245 Syndax Pharmaceuticals shares in Q2 2026, an estimated $317K.
Syndax Pharmaceuticals made up 5.05% of David M. Knott Jr's portfolio in Q2 2026, its #3 holding.
David M. Knott Jr first reported a position in Syndax Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
David M. Knott Jr's Syndax Pharmaceuticals position peaked at $9.86M in Q1 2026.
242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.